nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C8—Mometasone—systemic scleroderma	0.179	0.392	CbGbCtD
Triazolam—CYP2C9—Leflunomide—systemic scleroderma	0.0805	0.176	CbGbCtD
Triazolam—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0741	0.162	CbGbCtD
Triazolam—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0713	0.156	CbGbCtD
Triazolam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0289	0.0633	CbGbCtD
Triazolam—CYP3A4—Prednisone—systemic scleroderma	0.0231	0.0506	CbGbCtD
Triazolam—CYP2C9—cardial valve—systemic scleroderma	0.00755	0.366	CbGeAlD
Triazolam—TSPO—artery—systemic scleroderma	0.00186	0.09	CbGeAlD
Triazolam—TSPO—blood vessel—systemic scleroderma	0.00145	0.0701	CbGeAlD
Triazolam—Constipation—Captopril—systemic scleroderma	0.00112	0.00214	CcSEcCtD
Triazolam—Flatulence—Lisinopril—systemic scleroderma	0.00112	0.00214	CcSEcCtD
Triazolam—Tension—Lisinopril—systemic scleroderma	0.00111	0.00213	CcSEcCtD
Triazolam—Palpitations—Mycophenolic acid—systemic scleroderma	0.00111	0.00213	CcSEcCtD
Triazolam—Dysgeusia—Lisinopril—systemic scleroderma	0.00111	0.00213	CcSEcCtD
Triazolam—Discomfort—Leflunomide—systemic scleroderma	0.00111	0.00213	CcSEcCtD
Triazolam—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00111	0.00212	CcSEcCtD
Triazolam—Nervousness—Lisinopril—systemic scleroderma	0.0011	0.00211	CcSEcCtD
Triazolam—Affect lability—Prednisone—systemic scleroderma	0.0011	0.00211	CcSEcCtD
Triazolam—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00211	CcSEcCtD
Triazolam—Dry mouth—Leflunomide—systemic scleroderma	0.0011	0.0021	CcSEcCtD
Triazolam—Vomiting—Pentoxifylline—systemic scleroderma	0.0011	0.0021	CcSEcCtD
Triazolam—Muscle spasms—Lisinopril—systemic scleroderma	0.00109	0.00209	CcSEcCtD
Triazolam—Hypertension—Mycophenolic acid—systemic scleroderma	0.00109	0.00208	CcSEcCtD
Triazolam—Dermatitis—Pentoxifylline—systemic scleroderma	0.00109	0.00208	CcSEcCtD
Triazolam—Headache—Pentoxifylline—systemic scleroderma	0.00108	0.00207	CcSEcCtD
Triazolam—Feeling abnormal—Captopril—systemic scleroderma	0.00108	0.00206	CcSEcCtD
Triazolam—Chest pain—Mycophenolic acid—systemic scleroderma	0.00107	0.00205	CcSEcCtD
Triazolam—Gastrointestinal pain—Captopril—systemic scleroderma	0.00107	0.00205	CcSEcCtD
Triazolam—Anxiety—Mycophenolic acid—systemic scleroderma	0.00107	0.00204	CcSEcCtD
Triazolam—Asthenia—Mometasone—systemic scleroderma	0.00107	0.00204	CcSEcCtD
Triazolam—Irritability—Prednisone—systemic scleroderma	0.00107	0.00204	CcSEcCtD
Triazolam—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00204	CcSEcCtD
Triazolam—Tremor—Lisinopril—systemic scleroderma	0.00106	0.00203	CcSEcCtD
Triazolam—Mood swings—Prednisone—systemic scleroderma	0.00106	0.00203	CcSEcCtD
Triazolam—Discomfort—Mycophenolic acid—systemic scleroderma	0.00106	0.00203	CcSEcCtD
Triazolam—Pruritus—Mometasone—systemic scleroderma	0.00105	0.00202	CcSEcCtD
Triazolam—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00105	0.00201	CcSEcCtD
Triazolam—Tachycardia—Leflunomide—systemic scleroderma	0.00105	0.00201	CcSEcCtD
Triazolam—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00105	0.00201	CcSEcCtD
Triazolam—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00104	0.00199	CcSEcCtD
Triazolam—Hepatic failure—Methotrexate—systemic scleroderma	0.00104	0.00199	CcSEcCtD
Triazolam—Confusional state—Mycophenolic acid—systemic scleroderma	0.00104	0.00198	CcSEcCtD
Triazolam—Abdominal pain—Captopril—systemic scleroderma	0.00103	0.00198	CcSEcCtD
Triazolam—Oedema—Mycophenolic acid—systemic scleroderma	0.00103	0.00197	CcSEcCtD
Triazolam—Anorexia—Leflunomide—systemic scleroderma	0.00103	0.00197	CcSEcCtD
Triazolam—Nausea—Pentoxifylline—systemic scleroderma	0.00102	0.00196	CcSEcCtD
Triazolam—GABRR2—tendon—systemic scleroderma	0.00102	0.0496	CbGeAlD
Triazolam—Malaise—Lisinopril—systemic scleroderma	0.00102	0.00196	CcSEcCtD
Triazolam—Diarrhoea—Mometasone—systemic scleroderma	0.00102	0.00195	CcSEcCtD
Triazolam—Syncope—Lisinopril—systemic scleroderma	0.00102	0.00195	CcSEcCtD
Triazolam—Shock—Mycophenolic acid—systemic scleroderma	0.00101	0.00194	CcSEcCtD
Triazolam—Tachycardia—Mycophenolic acid—systemic scleroderma	0.001	0.00192	CcSEcCtD
Triazolam—Palpitations—Lisinopril—systemic scleroderma	0.001	0.00192	CcSEcCtD
Triazolam—Loss of consciousness—Lisinopril—systemic scleroderma	0.000997	0.00191	CcSEcCtD
Triazolam—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000994	0.0019	CcSEcCtD
Triazolam—Muscular weakness—Prednisone—systemic scleroderma	0.000987	0.00189	CcSEcCtD
Triazolam—Visual disturbance—Methotrexate—systemic scleroderma	0.000987	0.00189	CcSEcCtD
Triazolam—Anorexia—Mycophenolic acid—systemic scleroderma	0.00098	0.00188	CcSEcCtD
Triazolam—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000979	0.00187	CcSEcCtD
Triazolam—Tension—Mycophenolate mofetil—systemic scleroderma	0.000975	0.00187	CcSEcCtD
Triazolam—Insomnia—Leflunomide—systemic scleroderma	0.000974	0.00187	CcSEcCtD
Triazolam—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000973	0.00186	CcSEcCtD
Triazolam—Paraesthesia—Leflunomide—systemic scleroderma	0.000967	0.00185	CcSEcCtD
Triazolam—Chest pain—Lisinopril—systemic scleroderma	0.000966	0.00185	CcSEcCtD
Triazolam—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000965	0.00185	CcSEcCtD
Triazolam—Anxiety—Lisinopril—systemic scleroderma	0.000962	0.00184	CcSEcCtD
Triazolam—Dyspnoea—Leflunomide—systemic scleroderma	0.00096	0.00184	CcSEcCtD
Triazolam—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000955	0.00183	CcSEcCtD
Triazolam—Discomfort—Lisinopril—systemic scleroderma	0.000954	0.00183	CcSEcCtD
Triazolam—Vomiting—Mometasone—systemic scleroderma	0.000946	0.00181	CcSEcCtD
Triazolam—Dry mouth—Lisinopril—systemic scleroderma	0.000944	0.00181	CcSEcCtD
Triazolam—Sweating increased—Prednisone—systemic scleroderma	0.000942	0.0018	CcSEcCtD
Triazolam—Feeling abnormal—Azathioprine—systemic scleroderma	0.00094	0.0018	CcSEcCtD
Triazolam—Asthenia—Captopril—systemic scleroderma	0.000938	0.0018	CcSEcCtD
Triazolam—Dermatitis—Mometasone—systemic scleroderma	0.000938	0.00179	CcSEcCtD
Triazolam—Decreased appetite—Leflunomide—systemic scleroderma	0.000937	0.00179	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—systemic scleroderma	0.000935	0.00179	CcSEcCtD
Triazolam—Confusional state—Lisinopril—systemic scleroderma	0.000933	0.00179	CcSEcCtD
Triazolam—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000933	0.00179	CcSEcCtD
Triazolam—Headache—Mometasone—systemic scleroderma	0.000932	0.00178	CcSEcCtD
Triazolam—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00178	CcSEcCtD
Triazolam—Insomnia—Mycophenolic acid—systemic scleroderma	0.00093	0.00178	CcSEcCtD
Triazolam—Fatigue—Leflunomide—systemic scleroderma	0.000929	0.00178	CcSEcCtD
Triazolam—Oedema—Lisinopril—systemic scleroderma	0.000926	0.00177	CcSEcCtD
Triazolam—Pruritus—Captopril—systemic scleroderma	0.000925	0.00177	CcSEcCtD
Triazolam—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000923	0.00177	CcSEcCtD
Triazolam—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000922	0.00176	CcSEcCtD
Triazolam—Constipation—Leflunomide—systemic scleroderma	0.000921	0.00176	CcSEcCtD
Triazolam—Pain—Leflunomide—systemic scleroderma	0.000921	0.00176	CcSEcCtD
Triazolam—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000916	0.00175	CcSEcCtD
Triazolam—Somnolence—Mycophenolic acid—systemic scleroderma	0.000914	0.00175	CcSEcCtD
Triazolam—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000913	0.00175	CcSEcCtD
Triazolam—Shock—Lisinopril—systemic scleroderma	0.000911	0.00174	CcSEcCtD
Triazolam—Tachycardia—Lisinopril—systemic scleroderma	0.000903	0.00173	CcSEcCtD
Triazolam—Abdominal pain—Azathioprine—systemic scleroderma	0.000902	0.00173	CcSEcCtD
Triazolam—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000896	0.00172	CcSEcCtD
Triazolam—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000895	0.00171	CcSEcCtD
Triazolam—Diarrhoea—Captopril—systemic scleroderma	0.000894	0.00171	CcSEcCtD
Triazolam—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000893	0.00171	CcSEcCtD
Triazolam—Irritability—Methotrexate—systemic scleroderma	0.000892	0.00171	CcSEcCtD
Triazolam—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000891	0.00171	CcSEcCtD
Triazolam—Feeling abnormal—Leflunomide—systemic scleroderma	0.000888	0.0017	CcSEcCtD
Triazolam—Fatigue—Mycophenolic acid—systemic scleroderma	0.000886	0.0017	CcSEcCtD
Triazolam—Mood swings—Methotrexate—systemic scleroderma	0.000886	0.0017	CcSEcCtD
Triazolam—Nausea—Mometasone—systemic scleroderma	0.000884	0.00169	CcSEcCtD
Triazolam—Anorexia—Lisinopril—systemic scleroderma	0.000882	0.00169	CcSEcCtD
Triazolam—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000881	0.00169	CcSEcCtD
Triazolam—Ataxia—Methotrexate—systemic scleroderma	0.000879	0.00168	CcSEcCtD
Triazolam—Pain—Mycophenolic acid—systemic scleroderma	0.000879	0.00168	CcSEcCtD
Triazolam—Constipation—Mycophenolic acid—systemic scleroderma	0.000879	0.00168	CcSEcCtD
Triazolam—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000878	0.00168	CcSEcCtD
Triazolam—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000873	0.00167	CcSEcCtD
Triazolam—Dizziness—Captopril—systemic scleroderma	0.000864	0.00165	CcSEcCtD
Triazolam—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000858	0.00164	CcSEcCtD
Triazolam—Abdominal pain—Leflunomide—systemic scleroderma	0.000852	0.00163	CcSEcCtD
Triazolam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000847	0.00162	CcSEcCtD
Triazolam—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000846	0.00162	CcSEcCtD
Triazolam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000843	0.00161	CcSEcCtD
Triazolam—Hypersensitivity—Azathioprine—systemic scleroderma	0.000841	0.00161	CcSEcCtD
Triazolam—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00084	0.00161	CcSEcCtD
Triazolam—Insomnia—Lisinopril—systemic scleroderma	0.000837	0.0016	CcSEcCtD
Triazolam—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000836	0.0016	CcSEcCtD
Triazolam—Paraesthesia—Lisinopril—systemic scleroderma	0.000831	0.00159	CcSEcCtD
Triazolam—Vomiting—Captopril—systemic scleroderma	0.000831	0.00159	CcSEcCtD
Triazolam—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000827	0.00158	CcSEcCtD
Triazolam—Dyspnoea—Lisinopril—systemic scleroderma	0.000825	0.00158	CcSEcCtD
Triazolam—Dermatitis—Captopril—systemic scleroderma	0.000823	0.00158	CcSEcCtD
Triazolam—Somnolence—Lisinopril—systemic scleroderma	0.000823	0.00158	CcSEcCtD
Triazolam—Headache—Captopril—systemic scleroderma	0.000819	0.00157	CcSEcCtD
Triazolam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000818	0.00157	CcSEcCtD
Triazolam—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000812	0.00156	CcSEcCtD
Triazolam—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000811	0.00155	CcSEcCtD
Triazolam—Decreased appetite—Lisinopril—systemic scleroderma	0.000805	0.00154	CcSEcCtD
Triazolam—Fatigue—Lisinopril—systemic scleroderma	0.000798	0.00153	CcSEcCtD
Triazolam—Shock—Mycophenolate mofetil—systemic scleroderma	0.000798	0.00153	CcSEcCtD
Triazolam—Hypersensitivity—Leflunomide—systemic scleroderma	0.000794	0.00152	CcSEcCtD
Triazolam—Pain—Lisinopril—systemic scleroderma	0.000792	0.00152	CcSEcCtD
Triazolam—Constipation—Lisinopril—systemic scleroderma	0.000792	0.00152	CcSEcCtD
Triazolam—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000792	0.00152	CcSEcCtD
Triazolam—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000784	0.0015	CcSEcCtD
Triazolam—Diarrhoea—Azathioprine—systemic scleroderma	0.000781	0.00149	CcSEcCtD
Triazolam—Nausea—Captopril—systemic scleroderma	0.000776	0.00149	CcSEcCtD
Triazolam—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000773	0.00148	CcSEcCtD
Triazolam—Asthenia—Leflunomide—systemic scleroderma	0.000773	0.00148	CcSEcCtD
Triazolam—Hallucination—Prednisone—systemic scleroderma	0.00077	0.00147	CcSEcCtD
Triazolam—Feeling abnormal—Lisinopril—systemic scleroderma	0.000763	0.00146	CcSEcCtD
Triazolam—Pruritus—Leflunomide—systemic scleroderma	0.000762	0.00146	CcSEcCtD
Triazolam—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000757	0.00145	CcSEcCtD
Triazolam—Dysuria—Methotrexate—systemic scleroderma	0.000756	0.00145	CcSEcCtD
Triazolam—Dizziness—Azathioprine—systemic scleroderma	0.000754	0.00144	CcSEcCtD
Triazolam—TSPO—connective tissue—systemic scleroderma	0.000742	0.036	CbGeAlD
Triazolam—Asthenia—Mycophenolic acid—systemic scleroderma	0.000737	0.00141	CcSEcCtD
Triazolam—Diarrhoea—Leflunomide—systemic scleroderma	0.000737	0.00141	CcSEcCtD
Triazolam—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000734	0.0014	CcSEcCtD
Triazolam—Abdominal pain—Lisinopril—systemic scleroderma	0.000732	0.0014	CcSEcCtD
Triazolam—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00139	CcSEcCtD
Triazolam—Pruritus—Mycophenolic acid—systemic scleroderma	0.000727	0.00139	CcSEcCtD
Triazolam—Vomiting—Azathioprine—systemic scleroderma	0.000725	0.00139	CcSEcCtD
Triazolam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000723	0.00138	CcSEcCtD
Triazolam—GABRA4—tendon—systemic scleroderma	0.000721	0.0349	CbGeAlD
Triazolam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00138	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—systemic scleroderma	0.00072	0.00138	CcSEcCtD
Triazolam—Dermatitis—Azathioprine—systemic scleroderma	0.000719	0.00138	CcSEcCtD
Triazolam—Headache—Azathioprine—systemic scleroderma	0.000715	0.00137	CcSEcCtD
Triazolam—Dizziness—Leflunomide—systemic scleroderma	0.000712	0.00136	CcSEcCtD
Triazolam—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000705	0.00135	CcSEcCtD
Triazolam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000703	0.00135	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—systemic scleroderma	0.000702	0.00134	CcSEcCtD
Triazolam—Pain—Mycophenolate mofetil—systemic scleroderma	0.000694	0.00133	CcSEcCtD
Triazolam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000694	0.00133	CcSEcCtD
Triazolam—Vomiting—Leflunomide—systemic scleroderma	0.000685	0.00131	CcSEcCtD
Triazolam—Hypersensitivity—Lisinopril—systemic scleroderma	0.000682	0.00131	CcSEcCtD
Triazolam—Dizziness—Mycophenolic acid—systemic scleroderma	0.00068	0.0013	CcSEcCtD
Triazolam—TSPO—smooth muscle tissue—systemic scleroderma	0.000679	0.0329	CbGeAlD
Triazolam—Dermatitis—Leflunomide—systemic scleroderma	0.000679	0.0013	CcSEcCtD
Triazolam—Nausea—Azathioprine—systemic scleroderma	0.000678	0.0013	CcSEcCtD
Triazolam—Headache—Leflunomide—systemic scleroderma	0.000675	0.00129	CcSEcCtD
Triazolam—GABRB3—connective tissue—systemic scleroderma	0.000674	0.0327	CbGeAlD
Triazolam—Erythema—Prednisone—systemic scleroderma	0.000674	0.00129	CcSEcCtD
Triazolam—TSPO—skin of body—systemic scleroderma	0.00067	0.0325	CbGeAlD
Triazolam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00128	CcSEcCtD
Triazolam—Asthenia—Lisinopril—systemic scleroderma	0.000664	0.00127	CcSEcCtD
Triazolam—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00127	CcSEcCtD
Triazolam—Pruritus—Lisinopril—systemic scleroderma	0.000655	0.00125	CcSEcCtD
Triazolam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000653	0.00125	CcSEcCtD
Triazolam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000647	0.00124	CcSEcCtD
Triazolam—Headache—Mycophenolic acid—systemic scleroderma	0.000644	0.00123	CcSEcCtD
Triazolam—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000641	0.00123	CcSEcCtD
Triazolam—Nausea—Leflunomide—systemic scleroderma	0.00064	0.00122	CcSEcCtD
Triazolam—Diarrhoea—Lisinopril—systemic scleroderma	0.000633	0.00121	CcSEcCtD
Triazolam—GABRP—lung—systemic scleroderma	0.000628	0.0304	CbGeAlD
Triazolam—Ill-defined disorder—Prednisone—systemic scleroderma	0.000625	0.0012	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—systemic scleroderma	0.000623	0.00119	CcSEcCtD
Triazolam—Agitation—Prednisone—systemic scleroderma	0.000619	0.00118	CcSEcCtD
Triazolam—Dizziness—Lisinopril—systemic scleroderma	0.000612	0.00117	CcSEcCtD
Triazolam—Nausea—Mycophenolic acid—systemic scleroderma	0.00061	0.00117	CcSEcCtD
Triazolam—Malaise—Prednisone—systemic scleroderma	0.000607	0.00116	CcSEcCtD
Triazolam—Syncope—Prednisone—systemic scleroderma	0.000604	0.00116	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—systemic scleroderma	0.000603	0.00115	CcSEcCtD
Triazolam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000598	0.00114	CcSEcCtD
Triazolam—Loss of consciousness—Prednisone—systemic scleroderma	0.000592	0.00113	CcSEcCtD
Triazolam—Vomiting—Lisinopril—systemic scleroderma	0.000589	0.00113	CcSEcCtD
Triazolam—Dermatitis—Lisinopril—systemic scleroderma	0.000583	0.00112	CcSEcCtD
Triazolam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000582	0.00111	CcSEcCtD
Triazolam—Hypertension—Prednisone—systemic scleroderma	0.000582	0.00111	CcSEcCtD
Triazolam—Headache—Lisinopril—systemic scleroderma	0.00058	0.00111	CcSEcCtD
Triazolam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000574	0.0011	CcSEcCtD
Triazolam—Anxiety—Prednisone—systemic scleroderma	0.000572	0.00109	CcSEcCtD
Triazolam—Discomfort—Prednisone—systemic scleroderma	0.000567	0.00108	CcSEcCtD
Triazolam—Erythema—Methotrexate—systemic scleroderma	0.000563	0.00108	CcSEcCtD
Triazolam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000555	0.00106	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—systemic scleroderma	0.000551	0.00106	CcSEcCtD
Triazolam—Nausea—Lisinopril—systemic scleroderma	0.00055	0.00105	CcSEcCtD
Triazolam—Oedema—Prednisone—systemic scleroderma	0.00055	0.00105	CcSEcCtD
Triazolam—GABRE—tendon—systemic scleroderma	0.000547	0.0265	CbGeAlD
Triazolam—Shock—Prednisone—systemic scleroderma	0.000541	0.00104	CcSEcCtD
Triazolam—Tachycardia—Prednisone—systemic scleroderma	0.000537	0.00103	CcSEcCtD
Triazolam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000536	0.00103	CcSEcCtD
Triazolam—TSPO—digestive system—systemic scleroderma	0.000536	0.026	CbGeAlD
Triazolam—Hyperhidrosis—Prednisone—systemic scleroderma	0.000532	0.00102	CcSEcCtD
Triazolam—GABRB2—lung—systemic scleroderma	0.000529	0.0256	CbGeAlD
Triazolam—Anorexia—Prednisone—systemic scleroderma	0.000524	0.001	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000522	0.001	CcSEcCtD
Triazolam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000987	CcSEcCtD
Triazolam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000978	CcSEcCtD
Triazolam—TSPO—tendon—systemic scleroderma	0.00051	0.0247	CbGeAlD
Triazolam—Headache—Mycophenolate mofetil—systemic scleroderma	0.000508	0.000973	CcSEcCtD
Triazolam—Malaise—Methotrexate—systemic scleroderma	0.000508	0.000972	CcSEcCtD
Triazolam—Insomnia—Prednisone—systemic scleroderma	0.000497	0.000952	CcSEcCtD
Triazolam—Paraesthesia—Prednisone—systemic scleroderma	0.000494	0.000945	CcSEcCtD
Triazolam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000922	CcSEcCtD
Triazolam—GABRE—lung—systemic scleroderma	0.00048	0.0232	CbGeAlD
Triazolam—Chest pain—Methotrexate—systemic scleroderma	0.000479	0.000917	CcSEcCtD
Triazolam—Decreased appetite—Prednisone—systemic scleroderma	0.000478	0.000915	CcSEcCtD
Triazolam—Fatigue—Prednisone—systemic scleroderma	0.000474	0.000907	CcSEcCtD
Triazolam—Discomfort—Methotrexate—systemic scleroderma	0.000474	0.000906	CcSEcCtD
Triazolam—Constipation—Prednisone—systemic scleroderma	0.00047	0.0009	CcSEcCtD
Triazolam—Confusional state—Methotrexate—systemic scleroderma	0.000463	0.000887	CcSEcCtD
Triazolam—Feeling abnormal—Prednisone—systemic scleroderma	0.000453	0.000867	CcSEcCtD
Triazolam—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00045	0.000861	CcSEcCtD
Triazolam—TSPO—lung—systemic scleroderma	0.000448	0.0217	CbGeAlD
Triazolam—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000444	0.00085	CcSEcCtD
Triazolam—Anorexia—Methotrexate—systemic scleroderma	0.000438	0.000838	CcSEcCtD
Triazolam—Abdominal pain—Prednisone—systemic scleroderma	0.000435	0.000832	CcSEcCtD
Triazolam—Insomnia—Methotrexate—systemic scleroderma	0.000416	0.000795	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—systemic scleroderma	0.000413	0.00079	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—systemic scleroderma	0.00041	0.000784	CcSEcCtD
Triazolam—Somnolence—Methotrexate—systemic scleroderma	0.000408	0.000782	CcSEcCtD
Triazolam—GABRB3—lung—systemic scleroderma	0.000407	0.0197	CbGeAlD
Triazolam—Hypersensitivity—Prednisone—systemic scleroderma	0.000405	0.000775	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—systemic scleroderma	0.000399	0.000765	CcSEcCtD
Triazolam—Fatigue—Methotrexate—systemic scleroderma	0.000396	0.000758	CcSEcCtD
Triazolam—Asthenia—Prednisone—systemic scleroderma	0.000394	0.000755	CcSEcCtD
Triazolam—Pain—Methotrexate—systemic scleroderma	0.000393	0.000752	CcSEcCtD
Triazolam—Pruritus—Prednisone—systemic scleroderma	0.000389	0.000745	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000379	0.000725	CcSEcCtD
Triazolam—Diarrhoea—Prednisone—systemic scleroderma	0.000376	0.00072	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000376	0.000719	CcSEcCtD
Triazolam—Dizziness—Prednisone—systemic scleroderma	0.000364	0.000696	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—systemic scleroderma	0.000363	0.000695	CcSEcCtD
Triazolam—Vomiting—Prednisone—systemic scleroderma	0.00035	0.000669	CcSEcCtD
Triazolam—Dermatitis—Prednisone—systemic scleroderma	0.000346	0.000663	CcSEcCtD
Triazolam—Headache—Prednisone—systemic scleroderma	0.000344	0.000659	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000339	0.000648	CcSEcCtD
Triazolam—CYP3A5—digestive system—systemic scleroderma	0.000332	0.0161	CbGeAlD
Triazolam—Asthenia—Methotrexate—systemic scleroderma	0.00033	0.000631	CcSEcCtD
Triazolam—CYP2C9—digestive system—systemic scleroderma	0.000327	0.0158	CbGeAlD
Triazolam—Nausea—Prednisone—systemic scleroderma	0.000327	0.000625	CcSEcCtD
Triazolam—Pruritus—Methotrexate—systemic scleroderma	0.000325	0.000622	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—systemic scleroderma	0.000314	0.000602	CcSEcCtD
Triazolam—Dizziness—Methotrexate—systemic scleroderma	0.000304	0.000582	CcSEcCtD
Triazolam—Vomiting—Methotrexate—systemic scleroderma	0.000292	0.000559	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—systemic scleroderma	0.000289	0.000554	CcSEcCtD
Triazolam—Headache—Methotrexate—systemic scleroderma	0.000288	0.000551	CcSEcCtD
Triazolam—CYP3A5—lung—systemic scleroderma	0.000277	0.0134	CbGeAlD
Triazolam—Nausea—Methotrexate—systemic scleroderma	0.000273	0.000522	CcSEcCtD
Triazolam—CYP3A4—digestive system—systemic scleroderma	0.000249	0.0121	CbGeAlD
